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Objectives. We assessed the relation between sympathetic nerve 
activity and disease activity of vasospastic angina. 
Background. The autonomic nervous ystem has been proposed 
to play a key role in attacks of vasospastic angina. A unique 
feature of vasospastic angina attacks is periodic fluctuation, 
which complicates the assessment ofdisease activity. 
Methods. Twenty.five patients with left anterior descending 
coronary artery (LAD) spasm were studied: 12 with recent onset of 
chest pain (group 1) and 13 free of angina for more than 3 months 
after discontinuing medication (group 2). Group 1 underwent 
iodine-123 metaiodobenzylguanidine (MIBG) imaging (in the 
active phase) and atropine-stress MIBG imaging early after 
diagnostic angiography, and repeat MIBG imaging when they 
were free of angina for more than 3 months with medication (in 
the stable phase). Group 2 also underwent MIBG imaging (in 
remission). On a bull's-eye map, quantitative analysis of percent 
uptake and washout rate of MIBG was performed regionally. 
Results. In group 1 in the active phase, the washout rate of the 
LAD territory was significantly lower than the rates in the stable 
phase, in remission and during atropine.stress MIBG imaging. 
The regional washout rate of the territories of the right coronary 
artery and the circumflex artery in the active phase was also 
significantly lower than that during atropine-stress MIBG imag- 
ing. The washout rate of the LAD territory in the active phase was 
significantly lower than the rates of the other two regions. In 
contrast, here were no significant differences in the distribution 
of regional percent uptake in every image. A similar distribution 
of washout rate was observed among roup 1 patients in the stable 
phase, in group 1 patients during atropine.stress MIBG imaging 
and in group 2 patients. 
Conclusions. The MIBG washout rate of the spasm-induced 
coronary artery territory changed according to the degree of 
disease activity. Thus, sympathetic nerve activity could reflect 
disease activity of vasospastic angina. 
(J Am Coil Cardiol 1996;28:460-4) 
One of the unique features of vasospastic angina is periodic 
fluctuation of anginal attacks (1). Moreover, spontaneous 
remissions are known to be common in patients with vasospas- 
tic angina (2,3). This feature of the disease complicates the 
precise valuation of any therapeutic ntervention. Therefore, 
it is important to assess disease activity of vasospastic angina. 
Many investigators (4-9) have tried to assess disease activity of 
vasospastic angina. However, a useful means of assessing 
disease activity remains to be developed. The difficulty in 
assessing disease activity results from the unknown mecha- 
nisms contributing to this fluctuation of anginal attacks. How- 
ever, the autonomic nervous ystem has been proposed as 
playing a key role in attacks of vasospastic angina or coronary 
spasm (10-14). 
Recently, iodine-123 metaiodobenzylguanidine (MIBG)--an 
analogue of norepinephrine which also shares the same up- 
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take, storage and release mechanisms a  norepinephrine-- 
enables imaging of regional cardiac sympathetic innervation 
and has been shown to be a valuable clinical tool for the 
assessment of sympathetic nerve activity (15-19). 
To assess the relation between autonomic nervous ystem 
activity and disease activity of vasospastic angina, this study 
examined the regional activity of the sympathetic nervous 
system in patients with vasospastic angina who underwent 
MIBG imaging at various tages of disease actMty. 
Methods  
Patients. Twenty-five patients with vasospastic angina >50 
years old who underwent cardiac atheterization in our hospi- 
tal were selected for the present study. The patients were 
classified into two groups: 12 patients with acetylcholine- 
induced coronary spasm whose chest pain began to occur 
within 3 months before admission (group 1 = age 61 ___ 2 years; 
10 men, 2 women), and 13 patients with acetylcholine-induced 
coronary spasm whose chest pain had disappeared for >1 year 
while receiving antianginal drugs and did not recur for more 
than 3 months after discontinuing antianginal drugs (group 2 = 
age 61 _+ 4 years; i1 men, 2 women). In group 1, eight patients 
had completely normal coronary arteries, and the remaining 
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four patients had mild arteriosclerotic plaque at the site of 
spasm (<50%). In group 2, 10 patients had completely normal 
coronary arteries, and the remaining three patients had mild 
arteriosclerotic plaque at the site of spasm (<50%). All 
patients had normal left ventricular function and demonstrated 
>99% vasoconstriction accompanying ischemic electrocardio- 
graphic (ECG) changes and chest pain by acetylcholine infu- 
sion only in the proximal portion of the left anterior descend- 
ing coronary artery. All patients with vasospastic angina usually 
had chest pain occurring at rest and at least once a week before 
taking antianglnal drugs. However, we could not document 
spontaneous i chemic attacks with ischemic ST segment 
changes in any of the patients with vasospastic angina. None of 
the patients had any chest pain after taking antianginal drugs. 
None of the patients had a history of myocardial infarction, 
diabetes mellitus or any other diseases affecting the autonomic 
nervous system. Informed consent was obtained from each 
patient. This study protocol was approved by the hospital's 
ethics committee. 
Coronary angiography. After discontinuing antianginal 
drugs for several days, except for sublingual nitroglycerin, 
coronary angiography was performed. Before coronary angiog- 
raphy, a temporary pacing catheter was inserted into the right 
ventricle through the femoral vein; this was connected to a 
pulse generator with a demand-driven rate of 40 beats/min. 
Standard 12-lead ECGs were recorded continuously with a 
six-channel recorder. After control coronary arteriograms were 
obtained, acetylcholine, which had been dissolved in saline 
solution, was injected in incremental doses of 20 and 100/zg 
directly into the right coronary and subsequently the left 
coronary artery through a Judkins catheter. Coronary anglog- 
raphy was performed 1 min after acetylcholine was injected 
over l min. Acetyleholine administration was stopped and 
coronary angiography was performed immediately after the 
onset of chest pain accompanied by ischemic ECG changes. 
Chest pain was relieved promptly, either spontaneously or by 
intracoronary injection of nitroglycerin. After the acetylcholine 
provocation test, coronary angiography was performed after 
intracoronary injection of 0.3 mg of nitroglycerin. The results 
of coronary angiography after injection of nitroglycerin were 
classified according to the reporting system of the American 
Heart Association. Coronary artery spasm induced by acetyl- 
choline was considered present if total or subtotal occlusion 
(>99% vasoconstriction) of the involved artery occurred in 
association with chest pain and ischemic ST segment changes 
(>0.1-mV ST segment elevation or depression from the con- 
trol level). After coronary angiography, patients with coronary 
artery spasm resumed taking antianginal drugs. 
MIBG seintigraphy. One week after coronary angiogra- 
phy, all patients in group I underwent cardiac MIBG imaging 
while taking antianginal drugs (active phase). During follow- 
up, all patients in group 1 underwent repeat MIBG scintigra- 
phy when their attacks disappeared with drug administration 
for >3 months (9 _+ 3 months after onset; stable phase). At this 
time, chest pain and ischemic ST-T segment changes on the 
ECGs had disappeared completely in all patients. All patients 
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Figure 1. Definition of the territories of the three major coronary 
arteries on a polar map for iodine-123 metaiodobenzylguanidine 
imaging. LAD = left anterior descending coronary artery; RCA = 
right coronary artery; LCX = left circumflex artery. 
in group 2 underwent MIBG scintigraphy at least 3 months 
(4 _+ 1 months) after discontinuing antianginal drugs (in 
remission). None of the patients in group 2 demonstrated 
ischemic hanges on the ECGs or chest pain after discontinu- 
ing drugs. 
A dose of 111 MBq of commercially available MIBG 
(Daiichi Radioisotopes Labs. Ltd., Tokyo, Japan) was admin- 
istered intravenously from 9 to 10 AM after undisturbed supine 
bed rest for 15 min. Cardiac single-photon emission computed 
tomographic (SPECT) images were acquired 15 min (initial 
image) and 3 h (delayed image) after the injection of MIBG, 
using a three-head gamma camera (Toshiba GCA 9300A/HG, 
Tokyo, Japan) with 120 ° rotation per head in 3 ° increments, 
30 s per step and a 128 × 128 matrix. The data were 
reconstructed byfiltered backprojection (Shepp-Logan) on a 
Toshiba GMS 5500A system. Neither scatter correction or 
attenuation correction was performed. 
Oblique tomographic slices on the short, vertical long and 
horizontal long axes were computed and displayed. For semi- 
quantitative analysis, relative MIBG uptake of the left ventricle 
was calculated in all short-axis lices using a modified three- 
dimensional region of interest algorithm (20) and setting the 
maximal MIBG uptake at 100%. On a polar map representa- 
tion, the territory in each of the three major coronary arteries 
is demonstrated in Figure 1. 
Quantitative analysis of the washout rate of MIBG was also 
performed. Regional washout rates from the heart were cal- 
culated using initial and delayed images. The regional washout 
rate was obtained using the following formula: Regional 
washout rate (%) = (A - B)/A × 100, where A = average 
counts in a region on the initial image; and B = average 
decay-corrected counts at the same region on the delayed 
image. Decay correction was performed assuming that the 
half-life of radionuclide (iodine-123) was 13 h. 
Atropine-stress test. One week after the first MIBG imag- 
ing scans were taken, all patients in group 1 underwent 
atropine-stress MIBG imaging. Electrocardiographic monitor- 
ing was performed throughout the test. Blood pressure was 
recorded before and every I min after atropine injection until 
the injection of MIBG. After supine bed rest for 15 min, 1 mg 
of atropine was injected intravenously. This dose of atropine 
has been reported to suppress coronary artery spasm (10). 
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Figure 2. Polar maps for iodine-123 metaiodobenzylguanidine 
(MIBG) depicting regional percent uptake and regional washout rate 
of MIBG in the territory of the three major coronary arteries in 
patients with left anterior descending coronary artery spasm. Scans 
were performed atthe various tages of disease activity. Group 1 = 12 
patients with chest pain within 3 months of admission; Group 2 - 13 
patients with no chest pain for > 1 year during antianginal drug therapy 
and no recurrence for >3 months after discontinuing antianginal 
drugs; Atropine = MIBG imaging after 1 mg of atropine injection. 
#p < 0.05; ##p < 0.01; *p < 0.02; **p < 0.001 versus active phase. 
Results hown are mean value +_ SD. 
MIBG was injected 3 rain after the atropine injection. MIBG 
images were obtained 15 rain and 3 h after the injection of 111 
MBq of MIBG. 
Statistical analysis. Results are expressed as mean value +_ 
SD. Two-way repeated measures analysis of variance 
(ANOVA) was used to compare the regional percent uptake 
and regional washout rate of each region in the serial imaging 
and within three regions in each image by one-way ANOVA 
followed by a Bonferroni multiple comparison test. Significant 
differences were recognized at p < 0.05. 
Resu l ts  
Regional MIBG uptake. The results of the regional MIBG 
uptake in patients with coronary artery spasm are illustrated in 
Figure 2. As shown in Figure 2, uptake of MIBG in the left 
ventricle shows a similar heterogeneous di tribution in both 
groups. There were no significant differences in the regional 
MIBG uptake between group 1 in the active phase or in other 
phases and group 2. 
Regional washout rate. Figure 2 also shows the regional 
washout rate in the two groups. In group 1 in the active phase, 
the regional washout rate of the territory of the left anterior 
descending coronary artery was significantly lower than the 
rates of the circumflex artery territory (p < 0.02) and the right 
coronary artery territory (p < 0.05). However, there were no 
significant differences among the three regions in the other 
phases. The regional washout rate of the territory of the left 
anterior descending coronary artery in the active phase was 
significantly lower than that in the other phases (p < 0.01 
compared with the value in the stable phase, p < 0.01 
compared with the value in remission and p < 0.001 compared 
with the value in the atropine-stress test). Also, the regional 
washout rates of the territories of the right coronary artery and 
the circumflex artery in the active phase were significantly 
lower than those in the atropine-stress test (p < 0.02 and p < 
0.05, respectively). 
Serial MIBG scintigraphy: case report (Fig. 3). A 58-year 
old man was referred to our hospital for chest pain occurring 
from midnight o early morning. Coronary angiography re- 
vealed acetylcholine-induced spasm in the left anterior de- 
scending coronary artery. He was given antianginal drugs 
immediately after angiography and the anginal attacks disap- 
peared. One week after the diagnostic angiogram, he under- 
went MIBG imaging. Thereafter, his anginal attacks com- 
pletely disappeared. Approximately 1 year later, he underwent 
follow-up MIBG imaging. The washout rate in the left anterior 
descending coronary artery territory was markedly higher than 
that seen on the first MIBG imaging scan. In early August 
1995, chest pain between midnight and early morning recurred. 
One month after reemergence of chest pain, he underwent 
MIBG imaging. At this time, the increased washout rate in the 
left anterior descending coronary artery territory on the second 
MIBG imaging scan was markedly reduced. 
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Figure 3. Serial polar maps of iodine-123 metaiodo- 
benzylguanidine (MIBG) depicting regional MIBG 
percent uptake and regional washout rate in the Delayed 
territory of the three major coronary arteries in a Image 
representative patient with reemergence of chest pain. {%1 
Washout 
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Discuss ion  
The present study demonstrates that patients with left 
anterior descending coronary artery spasm showed a reduced 
washout rate of MIBG early after the onset of chest pain, 
which subsequently increased with disappearance of anginal 
attacks, especially in the spasm-induced coronary artery terri- 
tory. 
Contradiction to previous studies. Using MIBG imaging, 
the integrity of the myocardial sympathetic nervous ystem has 
been studied in various heart diseases (15-19). Reduced 
MIBG uptake and enhanced MIBG washout have been shown 
in ischemic heart disease. Both reduced MIBG uptake and 
enhanced MIBG washout are considered the result of dysin- 
nervation or denervation of sympathetic nerve endings, or 
both, mainly due to myocardial ischemia. Recently, patients 
with vasospastic angina have been shown to have regional 
sympathetic dysinnervation by visual assessment of MIBG 
imaging (20). However, sympathetic dysinnervation from car- 
diac ischemia is not negligible. In addition, it is sometimes 
difficult to assess MIBG imaging visually, especially in the 
inferior wall (15). Furthermore, gender- and age-related het- 
erogeneous distribution of MIBG has been reported (21). 
Thus, it is important o consider these factors in the MIBG 
studies. Therefore, we limited our study to patients with left 
anterior descending coronary artery spasm and normal left 
ventricular function, whose chest pains had been suppressed by 
antianginal drugs. In addition, the study subjects matched the 
factors noted above. Under these conditions, quantitative 
analysis of MIBG imaging showed that MIBG uptake in the 
heart was preserved in all study patients with coronary artery 
spasm, even in the active phase. However, regional washout 
rates of the spasm-induced coronary artery territory in the 
active phase were apparently reduced compared with those in 
the other stages. 
Atropine-stress MIBG scintigraphy. In the present study, 
atropine-stress MIBG imaging was performed to assess a 
mechanism of reduced washout rates in the active phase of 
vasospastic angina. As a result, atropine, an antimuscarinic 
drug, could enhance washout rates in each region, prominently 
in the spasm-induced coronary artery region, in the active 
phase of vasospastic angina. Given that atropine blocks pre- 
synaptic muscarinic receptors (22) and removes the inhibitory 
influence on the release of norepinephrine, one possible 
mechanism of the reduced washout rate of MIBG in the active 
phase of vasospastic angina is considered to be an inhibition of 
norepinephrine r lease from the presynaptic site. Considering 
the cardiac sympathetic-parasympathetic interactions at sym- 
pathetic nerve terminals and the effects of atropine on the 
parasympathetic nervous ystem, we speculate that the sympa- 
thetic nervous ystem in patients with vasospastic angina in the 
active phase might be suppressed by the parasympathetic 
nervous ystem, especially in the spasm-induced territory. This 
is partially supported by the reports that the parasympathetic 
nervous ystem is enhanced in vasospastic angina in the active 
phase (14,23). In contrast, atropine is well known to suppress 
acetylcholine-induced spasm clinically (10). Therefore, the 
MIBG images obtained after atropine injection were consid- 
ered to represent the sympathetic nerve activity in the heart, 
under which coronary spasm is difficult to induce. In the 
present study, this was clinically demonstrated bythe fact that 
the results of atropine-stress MIBG imaging were similar to 
those of MIBG imaging performed in the stable phase and 
remission. Thus, atropine-stress MIBG imaging may provide 
us with some important clinical information on vasospastic 
angina. 
Clinical implications. Fluctuation of ischemic attacks in 
vasospastic angina makes it very difficult to assess disease 
activity of vasospastic angina. Until now, exercise test (4), 
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ergonovine provocation alone (5,6) or combined with hyper- 
ventilation (7), ambulatory ECG monitoring (8) and measure- 
ment of blood components (9) have been proposed as means 
of assessing disease activity in vasospastic angina. However, the 
shortcomings of these tests make assessment of disease activity 
incomplete. In the present study, we demonstrated that non- 
invasive MIBG imaging, which can be easily and safely per- 
formed in patients with vasospastic angina in various clinical 
states, could provide a useful tool to assess disease activity. In 
fact, as shown in a case with recurrence ofischemic attacks, the 
washout rate in the spasm-induced coronary artery territory 
was reduced again when anginal attacks recurred, even though 
the patients continued taking antianginal drugs. Thus, MIBG 
imaging could help monitor disease activity of vasospastic 
angina. 
However, it has been suggested that the parasympathetic 
nervous ystem plays a major role in coronary spasm. Given 
that a period of marked imbalance of the sympathetic and 
parasympathetic nervous ystems has been shown to have a 
close relation to vasospastic angina activity (24), the sympa- 
thetic nerve activity in the spasm-induced coronary artery 
territory could reflect he disease activity of vasospastic angina. 
Conclusions. Using serial MIBG imaging, the present 
study showed that sympathetic nerve activity in the spasm- 
induced coronary artery territory changed according to disease 
activity in vasospastic angina. The present study suggested that 
serial MIBG imaging, including atropine-stress MIBG imag- 
ing, could help determine disease activity and the territory of 
the spasm-induced coronary artery in vasospastic angina, even 
though the study was limited to spasm in the left anterior 
descending coronary artery. 
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